HighTower Advisors LLC Has $11.90 Million Stock Holdings in iShares Biotechnology ETF $IBB

HighTower Advisors LLC raised its holdings in iShares Biotechnology ETF (NASDAQ:IBB) by 35.5% in the 4th quarter, according to the company in its most recent filing with the SEC. The firm owned 70,519 shares of the financial services provider’s stock after acquiring an additional 18,479 shares during the quarter. HighTower Advisors LLC’s holdings in iShares Biotechnology ETF were worth $11,901,000 as of its most recent SEC filing.

Several other large investors have also recently modified their holdings of the business. Brighton Jones LLC acquired a new position in shares of iShares Biotechnology ETF during the fourth quarter worth $201,000. AQR Capital Management LLC acquired a new stake in iShares Biotechnology ETF in the first quarter valued at $455,000. Millennium Management LLC increased its holdings in iShares Biotechnology ETF by 140.8% in the first quarter. Millennium Management LLC now owns 41,676 shares of the financial services provider’s stock valued at $5,330,000 after purchasing an additional 143,893 shares during the period. M&T Bank Corp raised its position in iShares Biotechnology ETF by 39.3% during the 2nd quarter. M&T Bank Corp now owns 2,660 shares of the financial services provider’s stock worth $337,000 after purchasing an additional 750 shares during the last quarter. Finally, Walleye Capital LLC raised its position in iShares Biotechnology ETF by 26.8% during the 2nd quarter. Walleye Capital LLC now owns 4,655 shares of the financial services provider’s stock worth $589,000 after purchasing an additional 985 shares during the last quarter. Institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Price Performance

iShares Biotechnology ETF stock opened at $168.79 on Monday. The stock’s 50 day moving average is $168.91 and its 200 day moving average is $169.98. iShares Biotechnology ETF has a one year low of $119.78 and a one year high of $179.64.

iShares Biotechnology ETF Cuts Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, March 20th. Stockholders of record on Tuesday, March 17th were given a $0.1218 dividend. The ex-dividend date was Tuesday, March 17th. This represents a $0.49 dividend on an annualized basis and a dividend yield of 0.3%.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.